FindMyKOL
Clinical trialNCT02290509CompletedPhase 3Interventional

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

SponsorProtein Sciences CorporationEnrollment1,350Influenza
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Randomized, double-blind trial of safety and immunogenicity of Flublok Quadrivalent versus Inactivated Influenza Vaccine (IIV4) in 1350 healthy, medically stable adults 18-49 years of age. Serum samples for Hemagglutinin Inhibition titers will be determined pre- and 28 days post-vaccination. Subjects will be followed for 6 months after vaccination for serious and/or medically-attended adverse events.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Benchmark Research - Sacramento

    Sacramento, California, United States

  • Clinical Research of South Florida

    Coral Gables, Florida, United States

  • Meridian Clinical Research

    Savannah, Georgia, United States

  • Heartland Research Associates, Llc

    Wichita, Kansas, United States

  • Benchmark Research

    Metairie, Louisiana, United States

  • Meridian Research

    Bellevue, Nebraska, United States

  • Meridian Clinical Research

    Omaha, Nebraska, United States

  • Meridian Research

    Dakota Dunes, South Dakota, United States

  • Benchmark Reseach

    Austin, Texas, United States

  • Benchmark Research - Fort Worth

    Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Flublok QuadrivalentInactivated Influenza Vaccine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2014
Primary completion
31 May 2015
Completion
31 May 2015
Last update posted
27 Oct 2016
Registered enrollment
1,350
Registry id
NCT02290509

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.